Ensign Peak Advisors »

Amylyx Pharmaceuticals shares owned by Ensign Peak Advisors

Quarter-by-quarter ownership of Amylyx Pharmaceuticals (AMLX) shares owned by Ensign Peak Advisors from 13F filings

Historical chart of Ensign Peak Advisors investment in Amylyx Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Amylyx Pharmaceuticals held by Ensign Peak Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Amylyx Pharmaceuticals by Ensign Peak Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $5.5M 305k 17.96

More positions owned by Ensign Peak Advisors

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)
Micron Technology (MU)
Eli Lilly & Co. (LLY)
JPMorgan Chase & Co. (JPM)
Mastercard Incorporated Cl A (MA)
Tesla Motors (TSLA)
Advanced Micro Devices (AMD)
Applied Materials (AMAT)

View all positions for Ensign Peak Advisors

Top funds holding Amylyx Pharmaceuticals

FMR
BlackRock
Perceptive Advisors
TCG Crossover Management
Commodore Capital
Jupiter Topco
Henderson Group
Saturn V Capital Management
Vanguard Capital Management
Driehaus Capital Management
First Light Asset Management
Franklin Resources
Goldman Sachs Group
State Street Corporation
Geode Capital Management

View all funds holding Amylyx Pharmaceuticals